| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,398 | 0,705 | 13:17 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12:10 | Saentra Forge: Sòphia High Tech Joins the LANSSET Committee of the Italian Chamber of Commerce in Singapore to Support Asia-Pacific Expansion | 248 | GlobeNewswire (Europe) | Sòphia HT, a Saentra Forge strategic investment, strengthens its access to aerospace and defense networks in Singapore and Southeast Asia, supporting industrial partnerships and business developmentMILAN... ► Artikel lesen | |
| 02.11. | GENENTA SCIENCE SPA: Genenta Unveils Saentra Forge as Its New Brand, Advancing Its Transformation into a Strategic Industrial Platform | 418 | GlobeNewswire (Europe) | Nasdaq Ticker to Change to 'SAEN' on November 4, 2026MILAN, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA) (the "Company") today announced that it will do business as Saentra... ► Artikel lesen | |
| 02.11. | Genenta Science S.p.A. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 21.10. | Genenta Science erhält NASDAQ-Mängelrüge wegen Unterschreitung des Mindestkurses | 1 | Investing.com Deutsch | ||
| GENENTA SCIENCE Aktie jetzt für 0€ handeln | |||||
| 21.10. | Genenta Science receives Nasdaq bid price deficiency notice | 2 | Investing.com | ||
| 21.10. | GENENTA SCIENCE SPA: Genenta Science Announces Receipt of Nasdaq Minimum Bid Price Deficiency Notification | 1 | GlobeNewswire (USA) | ||
| 21.10. | Genenta Science S.p.A. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 07.10. | Genenta Science S.p.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 15.09. | GENENTA SCIENCE SPA: Sòphia High Tech Flight Hardware on Board VEGA-C VV30 as the European Launcher Carries Sentinel-3C and FLEX into Orbit | 1 | GlobeNewswire (USA) | ||
| 11.09. | Genenta Science S.p.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 23.07. | GENENTA SCIENCE SPA: Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm | 626 | GlobeNewswire (Europe) | MILAN and NAPLES, Italy, July 23, 2026 (GLOBE NEWSWIRE) -- Sòphia High Tech S.r.l. (Sòphia HT), an Italian aerospace and defense company manufacturing critical parts for Europe's space and defense... ► Artikel lesen | |
| 22.07. | GENENTA SCIENCE SPA: Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results | 702 | GlobeNewswire (Europe) | Fiscal Year 2025 Highlights FY2025 sales rose 29.3% to €7.17 million; total value of production increased 34.7% to €8.47 millionEBITDA grew 68.1% to €1.61 million, expanding the EBITDA margin by approximately... ► Artikel lesen | |
| 14.07. | Genenta Science S.p.A. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 01.07. | Genenta Science S.p.A. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 24.06. | Genenta Science S.p.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 16.06. | Genenta Science S.p.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 23.04. | GENENTA SCIENCE SPA: Genenta signs Definitive Agreements with Sophia High Tech | 568 | GlobeNewswire (Europe) | MILAN,Italy, April 23, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA), evolving into Saentra Forge1, a strategic industrial consolidator focused on biotech, defense, aerospace, and... ► Artikel lesen | |
| 27.03. | GENENTA SCIENCE SPA: Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs | 960 | GlobeNewswire (Europe) | MILAN, March 27, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA), evolving into Saentra Forge1, a strategic industrial consolidator focused on biotech, defense, aerospace, and Italian... ► Artikel lesen | |
| 24.03. | GENENTA SCIENCE SPA: Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini | 449 | GlobeNewswire (Europe) | MILAN, March 24, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA) transforming to Saentra Forge1, a strategic industrial consolidator focused on biotech, defense, aerospace, and Italian... ► Artikel lesen | |
| 13.03. | GENENTA SCIENCE SPA: Genenta, Evolving into Saentra Forge, Announces CEO's Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University | 664 | GlobeNewswire (Europe) | MILAN, March 13, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA) transforming to Saentra Forge (Nasdaq: SAEN)1, a strategic industrial consolidator focused on biotech, defense, aerospace... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOTEC | 2,790 | -4,97 % | Evotec-Aktie: Gewinn- und Umsatzrekord? | Die Aktie des Hamburger Wirkstoffforschers Evotec bleibt ein spannender, aber risikoreicher Titel am deutschen Aktienmarkt. Nach schwierigen Monaten sorgen erste operative Fortschritte, neue Partnerschaften... ► Artikel lesen | |
| BB BIOTECH | 57,90 | 0,00 % | Christian Koch, Leiter BB Biotech Team bei Bellevue Asset Management, im Interview | von Robert Jakob Moneycab.com: Herr Koch, acht bestehende Beteiligungen verkauft, zwölf neue Positionen aufgebaut, das sieht nach einer grösseren Rochade aus? Die Veränderungen spiegeln unser aktives... ► Artikel lesen | |
| MODERNA | 198,52 | +1,35 % | Moderna nach 300 % Rallye: Droht jetzt eine größere Korrektur? | Seit August verzeichnete Moderna einen deutlichen Kursanstieg, auf den zuletzt eine Zwischenkorrektur folgte. Die bisher intakte Folge höherer Hochs und Tiefs sowie die zuletzt verteidigte 50-Tage-Linie... ► Artikel lesen | |
| BIOFRONTERA | 3,060 | +6,62 % | Biofrontera AG: Was der Umsatzsprung nicht verrät | ||
| CRISPR THERAPEUTICS | 36,440 | -0,72 % | CRISPR Therapeutics Highlights Substantial Lipid Reductions with Investigational Gene Editing Therapy | ||
| NANOREPRO | 1,360 | -2,16 % | NanoRepro: NuWays bleibt bei Kaufen - Paedi Protect läuft stärker als gedacht | ||
| AAP IMPLANTATE | 1,350 | -6,90 % | aap Implantate - Aktie vor Neubewertung? CEO und COO im Interview: "Die Basis steht, jetzt schalten wir auf Wachstum." | Eine spannende Sondersituation zeichnet sich derzeit bei der aap Implantate AG (ISIN: DE000A3H2101) ab: Nach Jahren der Restrukturierung und hohen regulatorischen Aufwendungen hat der Berliner Spezialist... ► Artikel lesen | |
| INOVIO PHARMACEUTICALS | 1,261 | -1,56 % | INOVIO Pharmaceuticals, Inc.: INOVIO Reports Third Quarter 2026 Financial Results and Recent Business Highlights | VOCERYQ (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd) granted accelerated approval by U.S. Food and Drug Administration (FDA) to reduce the frequency of surgery in adults with Recurrent... ► Artikel lesen | |
| CLINUVEL | 4,567 | -3,28 % | CLINUVEL PHARMACEUTICALS LIMITED: Change in substantial holding - Updated | ||
| INFLARX | 1,076 | +0,84 % | InflaRx im Check: Izicopan rückt vor, der Chart bleibt unter Druck | ||
| INTELLIA THERAPEUTICS | 8,960 | 0,00 % | Intellia auf der Jefferies Global Healthcare Conference: Marktstart und Pipeline im Fokus | ||
| TEMPUS AI | 61,31 | +4,11 % | Cathie Wood's weekly recap: boosts Nvidia, CoreWeave, Archer Aviation; pares Tempus AI, Palantir | ||
| DEFENCE THERAPEUTICS | 0,178 | +5,34 % | Defence Therapeutics Inc.: Defence Therapeutics Invites Shareholders to Its December 10, 2026, Annual General Meeting and 2027 Strategic Update | Montreal, Quebec--(Newsfile Corp. - November 16, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular... ► Artikel lesen | |
| EDITAS MEDICINE | 1,665 | -1,77 % | Editas auf der Guggenheim Healthcare Innovation Conference: Strategischer Fokus auf In-vivo-CRISPR | ||
| BIOCRYST PHARMACEUTICALS | 6,792 | +0,03 % | BioCryst presents real-world data on ORLADEYO at ACAAI meeting |